May 1 |
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
|
Apr 30 |
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
|
Apr 29 |
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
|
Mar 22 |
Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE
|
Mar 22 |
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
|
Mar 15 |
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript
|
Mar 15 |
Q4 2023 Eton Pharmaceuticals Inc Earnings Call
|
Mar 15 |
Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript
|
Mar 14 |
Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...
|
Mar 14 |
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
|